½ÃÀ庸°í¼­
»óǰÄÚµå
1402001

¼¼°èÀÇ ¿ø°Ý¾È°úÁø´Ü ½ÃÀå ¿¹Ãø(-2030³â) : ¼­ºñ½º À¯Çüº°, À¯Çüº°, Á¦°ø ¸ðµåº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° ºÐ¼®

Teleophthalmology Market Forecasts to 2030 - Global Analysis By Service Type (Teleretinal Imaging, Remote Diagnostics and Other Service Types), Type, Delivery Mode, Application, End User and By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Stratistics Market Research Consulting | ÆäÀÌÁö Á¤º¸: ¿µ¹® 200+ Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Stratistics MRC¿¡ µû¸£¸é, ¼¼°è ¿ø°Ý¾È°úÁø´Ü ½ÃÀåÀº ¿¹Ãø ±â°£ µ¿¾È CAGR 9.5%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¿ø°Ý Åë½Å ±â¼úÀ» ÀÌ¿ëÇØ ¿ø°Ý ¾È°ú ÀÇ·á ¼­ºñ½º¸¦ Á¦°øÇÏ´Â ¿ø°Ý¾È°úÁø´ÜÀº ¾È°ú ºÐ¾ß¿¡¼­ ¿ø°Ý ÀǷḦ Ȱ¿ëÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÌ »õ·Î¿î ¹æ¹ýÀº µðÁöÅÐ À̹ÌÁö ¹× È­»óȸÀÇ¿Í °°Àº µðÁöÅÐ Åë½Å µµ±¸¸¦ »ç¿ëÇÏ¿© ´Ù¾çÇÑ ´« ¹®Á¦¿¡ ´ëÇÑ ½Ç½Ã°£ Áø·á, Áø´Ü ¹× Ä¡·á °èȹÀ» Á¦°øÇÕ´Ï´Ù. ¿ø°Ý ¾È°ú ÀÇ·á´Â ÀΰøÁö´É ¹× ¿ø°Ý ¸ð´ÏÅ͸µ°ú °°Àº ÷´Ü ±â¼úÀ» Ȱ¿ëÇÏ¿© ¾È°ú ÀÇ·á¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» ³ôÀÌ°í ¾È°ú ÁúȯÀÇ Á¶±â Áø´Ü ¹× Ä¡·á¸¦ µ½½À´Ï´Ù.

¾È±¸ ÁúȯÀÇ À¯º´·ü Áõ°¡

³ëÈ­¼º Ȳ¹Ýº¯¼º, ´ç´¢¸Á¸·º´Áõ, ³ì³»Àå µîÀÇ Áúº´ÀÌ ¸¸¿¬Çϸ鼭 Àü ¼¼°èÀûÀ¸·Î ¾È°ú °ü·Ã ÁúȯÀÇ À¯º´·üÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Áõ°¡ÇÏ´Â °Ç°­ ¹®Á¦´Â ½Å¼ÓÇÑ Áø´Ü°ú Ä¡·á¸¦ À§ÇÑ Æí¸®ÇÑ ¿ø°Ý ¿É¼ÇÀ» Á¦°øÇÏ´Â ¿ø°Ý ¾È°ú¸¦ ÅëÇØ ÇØ°áµÇ°í ÀÖ½À´Ï´Ù. ¾È°ú ÀÇ·á ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä´Â ƯÈ÷ ÀÇ·á ¼­ºñ½º°¡ ºÎÁ·ÇÑ Áö¿ª°ú Áö¹æ¿¡¼­ Áõ°¡Çϰí ÀÖÀ¸¸ç, ¿ø°Ý ¾È°ú´Â ÀÌ·¯ÇÑ °ÝÂ÷¸¦ ÇØ¼ÒÇÒ ¼ö ÀÖ´Â ÇʼöÀûÀÎ µµ±¸°¡ µÇ°í ÀÖ½À´Ï´Ù. ÀÇ·á ¼­ºñ½º Á¦°øÀÚ´Â µðÁöÅÐ ¿µ»ó ±â¼ú°ú °¡»ó »ó´ãÀ» ÅëÇØ ¾È°ú ÁúȯÀ» ¿ø°ÝÀ¸·Î Áø´ÜÇϰí Ä¡·áÇÒ ¼ö ÀÖ¾î ȯÀÚ°¡ Àû½Ã¿¡ Ä¡·á¸¦ ¹ÞÀ» ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù.

µ¥ÀÌÅÍ º¸¾È ¹× °³ÀÎ Á¤º¸ º¸È£¿¡ °üÇÑ ¿ì·Á

¿ø°Ý ¾È°ú ÀÇ·á ¼­ºñ½º¸¦ ÀÌ¿ëÇÏ´Â »ç¶÷µéÀÌ ´Ã¾î³²¿¡ µû¶ó ȯÀÚÀÇ ±â¹Ð µ¥ÀÌÅ͸¦ º¸È£ÇÏ´Â °ÍÀÌ Å« °ü½É»ç·Î ¶°¿À¸£°í ÀÖ½À´Ï´Ù. ÀÇ·á µ¥ÀÌÅÍÀÇ µðÁöÅÐ Àü¼Û°ú ÀúÀåÀº »çÀ̹ö °ø°Ý°ú ¿øÄ¡ ¾Ê´Â Á¢±ÙÀ» ¹ÞÀ» ¼ö Àֱ⠶§¹®¿¡ °³ÀÎ ÀÇ·á Á¤º¸ÀÇ ¾ÈÀü¿¡ ´ëÇÑ ¿ì·Á°¡ Á¦±âµË´Ï´Ù. °ß°íÇÑ ¾ÈÀü ÇÁ·ÎÅäÄÝÀ» À¯ÁöÇÏ´Â °ÍÀº ȯÀÚ¿Í ÀÇ·á Àü¹®°¡ °£ÀÇ ½Å·Ú¸¦ ±¸ÃàÇÏ°í ¿ø°Ý ¾È°ú Ç÷§ÆûÀÇ °³ÀÎ Á¤º¸ º¸È£¿Í Á¤È®¼ºÀ» º¸ÀåÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù. ¹Ì±¹ÀÇ HIPAA¸¦ Æ÷ÇÔÇÑ ¾ö°ÝÇÑ µ¥ÀÌÅÍ º¸È£ ±ÔÁ¤À» ÁؼöÇØ¾ß Çϸç, °³ÀÎ Á¤º¸ º¸È£ Ç¥ÁØÀ» À¯ÁöÇϱâ À§ÇÑ Áö¼ÓÀûÀÎ ³ë·Â°ú ÀçÁ¤Àû ¾à¼ÓÀÌ ±ÔÁ¤µÇ¾î Àֱ⠶§¹®¿¡ µµÀÔ ÇÁ·Î¼¼½º°¡ ´õ¿í ¾î·Á¿öÁö°í ÀÖ½À´Ï´Ù.

±â¼úÀÇ ¹ßÀü

¾È°ú ÀÇ·á ¼­ºñ½º´Â µðÁöÅÐ Ä¿¹Â´ÏÄÉÀÌ¼Ç µµ±¸, °í¼Ó ÀÎÅÍ³Ý ¹× ÷´Ü ¿µ»ó ó¸® ÀåºñÀÇ ÅëÇÕÀ¸·Î °­È­µÇ°í ÀÖ½À´Ï´Ù. ½Ç½Ã°£ ÀÇ·á ¿µ»ó °øÀ¯, È¿À²ÀûÀÎ ¿ø°Ý Áø·á, ȯÀÚ¿Í ÀÇ·áÁøÀÇ È¿°úÀûÀÎ ¼ÒÅëÀº ¸ðµÎ ÀÌ·¯ÇÑ ±â¼ú ¹ßÀüÀ» ÅëÇØ °¡´ÉÇØÁ³½À´Ï´Ù. ¶ÇÇÑ Á¤±³ÇÑ À̹ÌÁö ºÐ¼®À» Ȱ¿ëÇϰí AI ¹× ±â°è ÇнÀ ¾Ë°í¸®ÁòÀ» ÅëÇÕÇÏ¿© Áø´ÜÀÇ Á¤È®¼ºÀ» Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú À¶ÇÕÀº ÀϹÝÀο¡°Ô Á¦°øµÇ´Â ¼­ºñ½º ¼öÁØÀ» ³ôÀÌ´Â µ¿½Ã¿¡ Àü¹® ¾È°ú ÀǷḦ ´õ¿í Ä£¼÷ÇÏ°Ô ¸¸µì´Ï´Ù.

±ÔÁ¦»óÀÇ °úÁ¦

¿ø°Ý ¾È°ú ÀÇ·á ¼­ºñ½º¸¦ Á¦°øÇÏ´Â °ø±ÞÀÚ´Â ÀÇ·á ±ÔÁ¦°¡ ¿ªµ¿ÀûÀ̰í Áö¿ª¸¶´Ù ´Ù¸£±â ¶§¹®¿¡ ºÒÈ®½Ç¼º¿¡ Á÷¸éÇÒ ¼ö ÀÖ½À´Ï´Ù. º¹ÀâÇÏ°í ´Ù¾çÇÑ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©¸¦ ÁؼöÇϱâ À§Çؼ­´Â ¸¹Àº Á¶Á¤°ú ÀçÁ¤Àû ÁöÃâÀÌ ÇÊ¿äÇϸç, ÀÌ´Â ½ÃÀå ¼ºÀå·üÀ» ÀúÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±ÔÁ¦ ±âÁØÀ» ÃæÁ·ÇÏ´Â °ÍÀº ¿ø°Ý ÀÇ·á ¼Ö·ç¼ÇÀÇ °³¹ß ¹× ¹èÆ÷¸¦ º¹ÀâÇÏ°Ô ¸¸µé°í ÀÖ½À´Ï´Ù. ¿ø°Ý ¾È°ú Ç÷§ÆûÀ» ÅëÇØ Àü´ÞµÇ´Â ȯÀÚ µ¥ÀÌÅÍÀÇ ÇÁ¶óÀ̹ö½Ã¿Í º¸¾ÈÀ» º¸È£ÇÏ´Â °ÍÀÌ °¡Àå Áß¿äÇÕ´Ï´Ù. ±×·¯³ª ÀϰüµÈ ¿ø°Ý ÀÇ·á Á¤Ã¥ÀÌ ¾ø±â ¶§¹®¿¡ ±ÔÁ¦ Àü·«¿¡ Â÷À̰¡ »ý°Ü ÀϰüµÇ°í Ç¥ÁØÈ­µÈ ¹æ½ÄÀ¸·Î ¿ø°Ý ¾È°ú ¼­ºñ½º¸¦ Àü ¼¼°è¿¡ µµÀÔÇÏ´Â µ¥ ¹æÇذ¡ µÉ ¼ö ÀÖ½À´Ï´Ù.

COVID-19ÀÇ ¿µÇâ:

ºÀ¼â¿Í »çȸÀû °Å¸®µÎ±â Á¶Ä¡ÀÇ ½ÃÇàÀ¸·Î ¿ø°Ý ÀÇ·á ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇß½À´Ï´Ù. ±× °á°ú, ¾È°ú Áø·á¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» À¯ÁöÇϱâ À§ÇØ ¿ø°Ý ¾È°ú Áø·á¿¡ ´ëÇÑ ÀÇÁ¸µµ°¡ ³ô¾ÆÁ³½À´Ï´Ù. ÀÌ·¯ÇÑ ÆÐ·¯´ÙÀÓÀÇ º¯È­´Â Á¤±â °ËÁø, °æ°ú °üÂû ¹× ºñÀÀ±Þ Áø·á¿¡¼­ ƯÈ÷ Áß¿äÇß½À´Ï´Ù. ÀÌ Àü¿°º´Àº ¿ø°Ý ¾È°úÀÇ °¡¿ë¼º°ú »ç¿ëÀÇ Æí¸®ÇÔÀ» ¹àÇô ȯÀÚ¿Í ÀÇ·á Àü¹®°¡°¡ ¿ø°Ý ¾È°ú¸¦ ¹Þ¾ÆµéÀÌ´Â µ¥ µµ¿òÀ̵Ǿú½À´Ï´Ù.

¿¹Ãø ±â°£ µ¿¾È ¿ø°Ý ¸Á¸· ¿µ»ó Áø´Ü ºÐ¾ß°¡ °¡Àå Å« ½ÃÀåÀ¸·Î ºÎ»óÇÒ °ÍÀ¸·Î ¿¹»ó

¿¹Ãø ±â°£ µ¿¾È ¿ø°Ý ¸Á¸· ¿µ»ó Áø´Ü ºÐ¾ß°¡ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀÔ´Ï´Ù. ¿ø°Ý ¾È°ú ÀÇ·á Áø´ÜÀÇ °­È­´Â µðÁöÅÐ ±â¼úÀ» »ç¿ëÇÏ¿© ¸Á¸·ÀÇ °íÇØ»óµµ À̹ÌÁö¸¦ ¼öÁýÇϰí Àü¼ÛÇÏ´Â ¿ø°Ý ¸Á¸· ¿µ»ó Áø´ÜÀÇ °³¹ßÀ» ÅëÇØ ½ÇÁúÀûÀ¸·Î ½ÇÇöµÇ°í ÀÖ½À´Ï´Ù. ÀÌ ±â¼úÀ» ÅëÇØ ÀÇ·á Àü¹®°¡´Â Á÷Á¢ ¹æ¹®ÇÏÁö ¾Ê°íµµ ³ëÈ­¼º Ȳ¹Ýº¯¼º, ´ç´¢¸Á¸·º´Áõ µî ´Ù¾çÇÑ ¸Á¸· ÁúȯÀ» ¿ø°ÝÀ¸·Î Æò°¡Çϰí Áø´ÜÇÒ ¼ö ÀÖ½À´Ï´Ù.

°¡»ó ¾ÆÀÌÄÉ¾î ºÐ¾ß´Â ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»ó

°¡»ó ¾È°ú ÀÇ·á ºÐ¾ß´Â Á¤È®ÇÑ ¿ø°Ý ¾È°ú ÀÇ·á ¼­ºñ½º¸¦ Á¦°øÇϱ⠶§¹®¿¡ ¼öÀͼºÀÌ ³ôÀº ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¾È°ú ÀÇ·á¿ë °¡»ó Ç÷§ÆûÀº ȯÀÚ¿Í ¾È°ú ÀÇ·áÁøÀÌ ¸ôÀÔÇü ½Ç½Ã°£ »óÈ£ÀÛ¿ëÀ» ÅëÇØ Á¾ÇÕÀûÀÎ °Ë»ç¿Í Æò°¡¸¦ ÇÒ ¼ö ÀÖ°Ô ÇØÁÝ´Ï´Ù. ȯÀÚ´Â °³º°È­µÈ Ä¡·á °èȹ°ú °¡»ó ¾È°ú °Ë»ç»Ó¸¸ ¾Æ´Ï¶ó ´Ù¾çÇÑ ¾È°ú ÁúȯÀÇ ½Ã°¢Àû ½Ã¹Ä·¹À̼ÇÀ» ÀÌ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, °¡»ó ¾È°ú ÀÇ·áÀÇ È¯ÀÚ Áß½ÉÀû Á¢±Ù ¹æ½Ä, »ç¿ë ÆíÀǼº ¹× Á¢±Ù¼ºÀº ¾È°ú ÀÇ·á ¼­ºñ½º Á¦°ø¿¡ Çõ½ÅÀ» °¡Á®¿Ô½À´Ï´Ù.

°¡Àå ³ôÀº Á¡À¯À²À» º¸ÀÌ´Â Áö¿ª:

½º¸¶Æ®Æù º¸±Þ·üÀÇ Áõ°¡¿Í ¿ø°Ý ÀÇ·áÀÇ ÀåÁ¡¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ¾Æ½Ã¾ÆÅÂÆò¾çÀÌ ÀÌ ºÕÀÇ °¡Àå Å« ºÎºÐÀ» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾ç¿¡¼­ ¿ø°Ý ¾È°ú ÀÇ·á°¡ Ȱ¼ºÈ­µÈ ÀÌÀ¯´Â ÀÌ Áö¿ªÀÇ Àα¸°¡ ¸¹°í ´Ù¾çÇϸç, ¿ø°ÝÁö¿¡¼­ÀÇ ÀüÅëÀûÀÎ ÀÇ·á ½Ã¼³ÀÇ ±¸Çö¿¡ ¾î·Á¿òÀÌ Àֱ⠶§¹®ÀÔ´Ï´Ù. ¿ø°Ý ¾È°ú°¡ È®´ëµÇ°í ÀÖ´Â °ÍÀº Áß±¹, ÇコÄÉ¾î µî °¢±¹ Á¤ºÎ¿Í ÀÇ·á ´ç±¹ÀÌ µðÁöÅÐ Çコ ÀÌ´Ï¼ÅÆ¼ºê¸¦ Àû±ØÀûÀ¸·Î ÃßÁøÇϰí Àֱ⠶§¹®ÀÔ´Ï´Ù.

CAGRÀÌ °¡Àå ³ôÀº Áö¿ª:

÷´Ü ±â¼ú ÀÎÇÁ¶ó, È®¸³µÈ ÀÇ·á ½Ã½ºÅÛ, µðÁöÅÐ °Ç°­ ¼Ö·ç¼Ç¿¡ ´ëÇÑ Àû±ØÀûÀÎ Á¢±ÙÀ¸·Î ºÏ¹Ì Áö¿ªÀº ¼öÀͼº ³ôÀº ¼ºÀåÀ» ÀÌ·ê °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿ø°Ý ¾È°ú Áø·á´Â ƯÈ÷ ¹Ì±¹°ú ij³ª´ÙÀÇ Ã·´Ü ÀÇ·á ½Ã½ºÅÛ¿¡¼­ ¾È°ú ÀÇ·á ¼­ºñ½º¿¡ ´ëÇÑ È¯ÀÚÀÇ Á¢±Ù¼ºÀ» Çâ»ó½ÃŰ´Â À¯¿ëÇÑ µµ±¸·Î Ȱ¿ëµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ Àα¸ÀÇ °í·ÉÈ­¿Í ¸¸¼º ¾ÈÁúȯÀÇ ºóµµ°¡ ³ô¾ÆÁö¸é¼­ ¿ø°Ý ¾È°ú ÀÇ·áÀÇ Á߿伺ÀÌ ´õ¿í °­Á¶µÇ°í ÀÖ½À´Ï´Ù.

¹«·á ¸ÂÃãÇü ¼­ºñ½º:

ÀÌ º¸°í¼­¸¦ ±¸µ¶ÇÏ´Â °í°´Àº ´ÙÀ½°ú °°Àº ¹«·á ¸ÂÃãÇü ¿É¼Ç Áß Çϳª¸¦ »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù:

  • ȸ»ç ÇÁ·ÎÇÊ
    • Ãß°¡ ½ÃÀå ±â¾÷ÀÇ Á¾ÇÕÀûÀÎ ÇÁ·ÎÆÄÀϸµ(ÃÖ´ë 3°³»ç±îÁö)
    • ÁÖ¿ä ±â¾÷ SWOT ºÐ¼®(3°³»ç±îÁö)
  • Áö¿ª ¼¼ºÐÈ­
    • °í°´ÀÇ °ü½É¿¡ µû¸¥ ÁÖ¿ä ±¹°¡º° ½ÃÀå ÃßÁ¤ ¹× ¿¹Ãø, CAGR(Âü°í: Ÿ´ç¼º °ËÅä¿¡ µû¸¥)
  • °æÀï»ç º¥Ä¡¸¶Å·
    • Á¦Ç° Æ÷Æ®Æú¸®¿À, Áö¸®Àû ÀÔÁö, Àü·«Àû Á¦ÈÞ¸¦ ±â¹ÝÀ¸·Î ÇÑ ÁÖ¿ä ±â¾÷ º¥Ä¡¸¶Å·

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼­¹®

  • °³¿ä
  • ÀÌÇØ°ü°èÀÚ
  • Á¶»ç ¹üÀ§
  • Á¶»ç ¹æ¹ý
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • µ¥ÀÌÅÍ ºÐ¼®
    • µ¥ÀÌÅÍ °ËÁõ
    • Á¶»ç Á¢±Ù¹ý
  • Á¶»ç ¼Ò½º
    • 1Â÷ Á¶»ç ¼Ò½º
    • 2Â÷ Á¶»ç ¼Ò½º
    • °¡Á¤

Á¦3Àå ½ÃÀå µ¿Ç⠺м®

  • ¼ºÀå ÃËÁø¿äÀÎ
  • ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ±âȸ
  • À§Çù
  • ¿ëµµ ºÐ¼®
  • ÃÖÁ¾»ç¿ëÀÚ ºÐ¼®
  • ½ÅÈï ½ÃÀå
  • ½ÅÁ¾ Äڷγª¹ÙÀÌ·¯½º °¨¿°Áõ(COVID-19)ÀÇ ¿µÇâ

Á¦4Àå Porter's Five Forces ºÐ¼®

  • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
  • ±¸¸ÅÀÚÀÇ ±³¼··Â
  • ´ëüǰÀÇ À§Çù
  • ½Å±Ô Âü¿©¾÷üÀÇ À§Çù
  • °æÀï ±â¾÷ °£ÀÇ °æÀï °ü°è

Á¦5Àå ¼¼°èÀÇ ¿ø°Ý¾È°úÁø´Ü ½ÃÀå : ¼­ºñ½º À¯Çüº°

  • ¿ø°Ý ¸Á¸· À̹Ì¡
  • ¿ø°Ý Áø´Ü
    • µðÁöÅÐ ±¼Àý
    • ¾È¾Ð ÃøÁ¤
    • ½Ã·Â °Ë»ç
  • ±âŸ ¼­ºñ½º À¯Çü

Á¦6Àå ¼¼°èÀÇ ¿ø°Ý¾È°úÁø´Ü ½ÃÀå : À¯Çüº°

  • À¥ ±â¹Ý
  • Ŭ¶ó¿ìµå ±â¹Ý
  • AI ±â¹Ý
  • ±âŸ À¯Çü

Á¦7Àå ¼¼°èÀÇ ¿ø°Ý¾È°úÁø´Ü ½ÃÀå : Á¦°ø ¸ðµåº°

  • ÀúÀå ÈÄ Àü´Þ ¼­ºñ½º
  • ½Ç½Ã°£ ÀÎÅÍ·¢Æ¼ºê ¼­ºñ½º
  • ±âŸ Á¦°ø ¸ðµå

Á¦8Àå ¼¼°èÀÇ ¿ø°Ý¾È°úÁø´Ü ½ÃÀå : ¿ëµµº°

  • °¡»ó ¾ÆÀÌÄɾî
  • ´ç´¢º´ ¸Á¸·Áõ ½ºÅ©¸®´×
  • Ȳ¹Ýº¯¼ºÁõ
  • ³ì³»Àå °ü¸®
  • ±âŸ ¿ëµµ

Á¦9Àå ¼¼°èÀÇ ¿ø°Ý¾È°úÁø´Ü ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ȨÄÉ¾î ¼³Á¤
  • Àü¹® ¾È°ú ¼¾ÅÍ
  • º´¿ø°ú Áø·á¼Ò
  • ±âŸ ÃÖÁ¾»ç¿ëÀÚ

Á¦10Àå ¼¼°èÀÇ ¿ø°Ý¾È°úÁø´Ü ½ÃÀå : Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • È£ÁÖ
    • ´ºÁú·£µå
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ³²¹Ì
    • ¾Æ¸£ÇîÆ¼³ª
    • ºê¶óÁú
    • Ä¥·¹
    • ±âŸ ³²¹Ì
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • īŸ¸£
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦11Àå ÁÖ¿ä ¹ßÀü

  • °è¾à, ÆÄÆ®³Ê½Ê, Çù¾÷, ÇÕÀÛÅõÀÚ
  • Àμö¿Í ÇÕº´
  • ½ÅÁ¦Ç° ¹ß¸Å
  • »ç¾÷ È®´ë
  • ±âŸ ÁÖ¿ä Àü·«

Á¦12Àå ±â¾÷ °³¿ä

  • Carl Zeiss Meditec AG
  • Clarity Medical Systems
  • doxy.me, LLC.
  • e-eyecare LTD.
  • EyecareLive, Inc
  • Eyenuk, Inc.
  • Leben Care Technologies Pte. Ltd.
  • Ophthalmic Imaging Systems
  • Pulse Telemedicine Technologies
  • Retina Labs USA Inc
  • Revenio Group Plc(CERA Technologies Pty Ltd)
  • Secure Diagnostic Imagery Ltd
  • VisionCare Inc
  • VisionQuest
  • Welcare Health Systems
ksm 24.01.11

According to Stratistics MRC, the Global Teleophthalmology Market is growing at a CAGR of 9.5% during the forecast period. Using telecommunications technology to deliver remote eye care services, teleophthalmology is the use of telemedicine in the field of ophthalmology. This novel method uses digital communication tools, like digital imaging and video conferencing, to provide real-time consultations, diagnosis, and treatment planning for an array of eye problems. Teleophthalmology expands access to eye care while assisting in the early diagnosis and treatment of eye illnesses by utilizing cutting-edge technologies such as artificial intelligence and remote monitoring.

Market Dynamics:

Driver:

Increasing prevalence of eye disorders

The prevalence of eye-related disorders is increasing worldwide, with illnesses like age-related macular degeneration, diabetic retinopathy, and glaucoma becoming more prevalent. This growing health issue is addressed by teleophthalmology, which provides a convenient and remote option for prompt diagnosis and treatment. The increasing need for eye care services, particularly in underserved or rural places, makes teleophthalmology an essential tool for addressing the gap. Healthcare providers can remotely diagnose and treat eye diseases using digital imaging technology and virtual consultations, ensuring that patients receive timely interventions.

Restraint:

Data security and privacy concerns

As more people use remote eye care services, protecting sensitive patient data becomes a major concern. Concerns over the security of personal health information are raised by the digital transmission and storage of medical data, as it may be subject to cyber-attacks or unwanted access. Sustaining robust safety protocols is essential for fostering confidence between patients and healthcare professionals and guaranteeing the privacy and accuracy of teleophthalmology platforms. The implementation process is made more difficult by the need to comply with strict data protection rules, including HIPAA in the US, that provide for ongoing efforts and financial commitments to maintain privacy standards.

Opportunity:

Advancements in technology

Delivering ophthalmic care has been enhanced by the integration of digital communication tools, high-speed internet, and advanced imaging instruments. Real-time medical image sharing, efficient remote consultations, and effective patient-provider communication are all made possible by these technological advancements. Furthermore, by using sophisticated envision analysis, the integration of AI and machine learning algorithms improves the precision of diagnosis. This technological convergence raises the standard of services rendered generally while also making specialized eye care more accessible.

Threat:

Regulatory challenges

Providers in teleophthalmology might experience uncertainty due to the dynamic and regionally varying nature of healthcare regulations. Adherence to complex and varied regulatory frameworks necessitates significant adjustment and financial outlay, which may impede the rate of market growth. Meeting these regulatory standards complicates the development and deployment of telemedicine solutions. Protecting the privacy and safety of patient data conveyed through teleophthalmology platforms is of the utmost significance. However, the lack of consistent telemedicine policies may result in variations in regulatory strategies, impeding the global adoption of teleophthalmology services in a consistent and standard manner.

COVID-19 Impact:

The implementation of lockdowns and social distancing measures resulted in an abrupt rise in the demand for remote healthcare services. This has led to a greater reliance on teleophthalmology to maintain access to eye care. This paradigm shift was especially important for routine screenings, follow-ups, and non-emergency consultations, as it reduced the risk of viral transmission while allowing patients to receive care on time. The epidemic brought teleophthalmology's availability and simplicity of use to light, which helped patients and healthcare professionals embrace it.

The teleretinal imaging segment is expected to be the largest during the forecast period

Teleretinal Imaging segment dominated the largest share over the forecast period. Enhancing remote eye care diagnostics has been feasible in a substantial manner through the development of teleretinal imaging, which uses digital technology to gather and transmit high-resolution images of the retina. Without requiring in-person visits, this technology enables healthcare professionals to remotely evaluate and diagnose a range of retinal disorders, such as age-related macular degeneration and diabetic retinopathy.

The virtual eye care segment is expected to have the highest CAGR during the forecast period

The virtual eye care sector is anticipated to grow profitably as it provides accurate, remote eye care services. Virtual platforms for eye care enable patients and eye care providers to interact in immersive, real-time interactions that enable comprehensive examinations and assessments. In addition to obtaining individualized treatment plans and virtual eye tests, patients have access to visual simulations of different eye disorders. Furthermore, virtual eye care's patient-centered approach, simplicity of use, and accessibility have transformed the provision of eye care services.

Region with largest share:

Due to rising smartphone adoption and growing awareness of the benefits of telemedicine, the Asia-Pacific region accounted for the largest portion of this boom. Teleophthalmology has flourished in the Asia Pacific because of the region's large and diversified population as well as the challenges involved with achieving traditional healthcare facilities in remote regions. Teleophthalmology is expanding because of the active promotion of digital health initiatives by governments and healthcare authorities in countries such as China and India.

Region with highest CAGR:

Because of its advanced technology infrastructure, well-established healthcare system, and proactive approach to digital health solutions, the North American region is anticipated to have profitable growth. Teleophthalmology is being used by the region's cutting-edge healthcare systems, especially in the US and Canada, as a useful tool to improve patient access to eye care services. Additionally, the aging population and the frequency of chronic eye disorders emphasize the importance of remote eye care alternatives even further.

Key players in the market:

Some of the key players in Teleophthalmology market include Carl Zeiss Meditec AG, Clarity Medical Systems, doxy.me, LLC., e-eyecare LTD., EyecareLive, Inc, Eyenuk, Inc., Leben Care Technologies Pte. Ltd., Ophthalmic Imaging Systems, Pulse Telemedicine Technologies , Retina Labs USA Inc, Revenio Group Plc (CERA Technologies Pty Ltd), Secure Diagnostic Imagery Ltd, VisionCare Inc, VisionQuest and Welcare Health Systems.

Key Developments:

In November 2023, Carl Zeiss Meditec AG's owners are private companies with 59% stake, while 21% is held by institutions. The group holding the most number of shares in the company, around 59% to be precise, is private companies. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn).

In October 2023, ZEISS and Boehringer Ingelheim join forces to develop early detection of eye diseases and prevent vision loss. The partnership brings together their leading expertise in ophthalmological technology, data analytics, algorithms and the development of first-in-class treatments to detect early and treat retinal diseases before irreversible vision loss occurs.

In September 2021, Wellcare Announces Refreshed Brand in Effort to Better Serve Medicare Members. Wellcare, a wholly owned subsidiary of Centene Corporation, announced its refreshed corporate Medicare brand in an effort to better align with the company's strategy, build stronger brand awareness, and support the company's mission to help its members live better, healthier lives.

Service Types Covered:

  • Teleretinal Imaging
  • Remote Diagnostics
  • Other Service Types

Types Covered:

  • Web-based
  • Cloud-Based
  • AI-based
  • Other Types

Delivery Modes Covered:

  • Store-and-Forward Services
  • Real-time Interactive Services
  • Other Delivery Modes

Applications Covered:

  • Virtual Eye Care
  • Diabetic Retinopathy Screening
  • Macular Degeneration
  • Glaucoma Management
  • Other Applications

End Users Covered:

  • Home Care Settings
  • Specialty Eye Centers
  • Hospitals and Clinics
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Teleophthalmology Market, By Service Type

  • 5.1 Introduction
  • 5.2 Teleretinal Imaging
  • 5.3 Remote Diagnostics
    • 5.3.1 Digital Refraction
    • 5.3.2 Intraocular Pressure Measurement
    • 5.3.3 Visual Acuity Testing
  • 5.4 Other Service Types

6 Global Teleophthalmology Market, By Type

  • 6.1 Introduction
  • 6.2 Web-based
  • 6.3 Cloud-Based
  • 6.4 AI-based
  • 6.5 Other Types

7 Global Teleophthalmology Market, By Delivery Mode

  • 7.1 Introduction
  • 7.2 Store-and-Forward Services
  • 7.3 Real-time Interactive Services
  • 7.4 Other Delivery Modes

8 Global Teleophthalmology Market, By Application

  • 8.1 Introduction
  • 8.2 Virtual Eye Care
  • 8.3 Diabetic Retinopathy Screening
  • 8.4 Macular Degeneration
  • 8.5 Glaucoma Management
  • 8.6 Other Applications

9 Global Teleophthalmology Market, By End User

  • 9.1 Introduction
  • 9.2 Home Care Settings
  • 9.3 Specialty Eye Centers
  • 9.4 Hospitals and Clinics
  • 9.5 Other End Users

10 Global Teleophthalmology Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Carl Zeiss Meditec AG
  • 12.2 Clarity Medical Systems
  • 12.3 doxy.me, LLC.
  • 12.4 e-eyecare LTD.
  • 12.5 EyecareLive, Inc
  • 12.6 Eyenuk, Inc.
  • 12.7 Leben Care Technologies Pte. Ltd.
  • 12.8 Ophthalmic Imaging Systems
  • 12.9 Pulse Telemedicine Technologies
  • 12.10 Retina Labs USA Inc
  • 12.11 Revenio Group Plc (CERA Technologies Pty Ltd)
  • 12.12 Secure Diagnostic Imagery Ltd
  • 12.13 VisionCare Inc
  • 12.14 VisionQuest
  • 12.15 Welcare Health Systems
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦